119 related articles for article (PubMed ID: 884851)
21. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
Scott CF; Silver LD; Schapira M; Colman RW
J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202
[TBL] [Abstract][Full Text] [Related]
22. Autoactivation of human plasma prekallikrein.
Tans G; Rosing J; Berrettini M; Lämmle B; Griffin JH
J Biol Chem; 1987 Aug; 262(23):11308-14. PubMed ID: 2440889
[TBL] [Abstract][Full Text] [Related]
23. [Use of a chromatographic method for determining kallikrein and prekallikrein in dog blood serum].
Dotsenko VL; Saiapin VN; Neshkova EA; Iarovaia GA
Biull Eksp Biol Med; 1982 Aug; 94(8):117-20. PubMed ID: 6922725
[TBL] [Abstract][Full Text] [Related]
24. High molecular weight kininogen potentiates the heparin-accelerated inhibition of plasma kallikrein by antithrombin: role for antithrombin in the regulation of kallikrein.
Olson ST; Sheffer R; Francis AM
Biochemistry; 1993 Nov; 32(45):12136-47. PubMed ID: 7692967
[TBL] [Abstract][Full Text] [Related]
25. Biochemical and functional properties of factor XI and prekallikrein.
Mannhalter CH
Semin Thromb Hemost; 1987 Jan; 13(1):25-35. PubMed ID: 3551075
[No Abstract] [Full Text] [Related]
26. Reduced or unchanged cofactor function of human high molecular weight kininogen induced by human plasma kallikrein.
Johansen HT; Briseid K
Adv Exp Med Biol; 1986; 198 Pt A():147-53. PubMed ID: 3492869
[TBL] [Abstract][Full Text] [Related]
27. Purification of human low molecular weight kininogen and its application for a simple ND sensitive method for determination of human urinary kallikrein activity.
Nakagawa M; Shimamoto K; Kondo M; Ura N; Nishitani T; Ishida H; Yokoyama T; Tanaka S; Iimura O
Adv Exp Med Biol; 1986; 198 Pt B():523-9. PubMed ID: 3643739
[TBL] [Abstract][Full Text] [Related]
28. Normal plasma arginine esterase and the Hageman factor (factor XII) -prekallikrein-kininogen system in cystic fibrosis.
Goldsmith GH; Stern RC; Saito H; Ratnoff OD
J Lab Clin Med; 1977 Jan; 89(1):131-4. PubMed ID: 830773
[TBL] [Abstract][Full Text] [Related]
29. Some molecular and functional changes in high molecular weight kininogen induced by plasmin and trypsin.
Kleniewski J; Donaldson VH; Wagner CJ
Thromb Res; 1982 Mar; 25(5):387-99. PubMed ID: 6176044
[TBL] [Abstract][Full Text] [Related]
30. [Various properties and kinetics of interaction of high and low molecular weight human kininogens with human plasma kallikrein].
Nartikova VF; Egorova TP; Rets EV; Paskhina TS
Biokhimiia; 1986 Mar; 51(3):463-71. PubMed ID: 3634630
[TBL] [Abstract][Full Text] [Related]
31. Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. II. Evidence relating the kaolin-activated arginine esterase to plasma kallikrein.
Colman RW; Mattler L; Sherry S
J Clin Invest; 1969 Jan; 48(1):23-32. PubMed ID: 4237065
[TBL] [Abstract][Full Text] [Related]
32. Studies of binding of prekallikrein and Factor XI to high molecular weight kininogen and its light chain.
Thompson RE; Mandle R; Kaplan AP
Proc Natl Acad Sci U S A; 1979 Oct; 76(10):4862-6. PubMed ID: 291905
[TBL] [Abstract][Full Text] [Related]
33. Prekallikrein activation and kallikrein inactivation in human plasma.
van der Graaf F; Keus JF; Koedam JA; Rietveld A; Bouma BN
Adv Exp Med Biol; 1983; 156():143-8. PubMed ID: 6190365
[No Abstract] [Full Text] [Related]
34. Role of arginine residues in the coagulant activity of high molecular weight kininogen.
Chang JJ; Scott CF; Colman RW
Blood; 1986 Mar; 67(3):805-10. PubMed ID: 3633200
[TBL] [Abstract][Full Text] [Related]
35. [Initiation mechanism of blood coagulation (author's transl)].
Kurachi K; Fujikawa K
Tanpakushitsu Kakusan Koso; 1980 Feb; 25(2):95-111. PubMed ID: 7008084
[No Abstract] [Full Text] [Related]
36. Localization of the binding site on plasma kallikrein for high-molecular-weight kininogen to both apple 1 and apple 4 domains of the heavy chain.
Page JD; You JL; Harris RB; Colman RW
Arch Biochem Biophys; 1994 Oct; 314(1):159-64. PubMed ID: 7944388
[TBL] [Abstract][Full Text] [Related]
37. Existence of prokallikrein in the kidney. Its biochemical properties compared to three active glandular kallikreins from the kidney, serum, and urine of the rat.
Nishimura K; Shimizu H; Kokubu T
Hypertension; 1983; 5(2):205-10. PubMed ID: 6550028
[TBL] [Abstract][Full Text] [Related]
38. Changes in plasma levels of prekallikrein, kallikrein, high molecular weight kininogen and kallikrein inhibitors during lethal endotoxin shock in dogs.
Gallimore MJ; Aasen AO; Amundsen E
Haemostasis; 1978; 7(2-3):79-84. PubMed ID: 658781
[TBL] [Abstract][Full Text] [Related]
39. Hageman factor-dependent pathways: mechanism of initiation and bradykinin formation.
Kaplan AP
Fed Proc; 1983 Nov; 42(14):3123-7. PubMed ID: 6556144
[TBL] [Abstract][Full Text] [Related]
40. Purification and characterization of rat low molecular weight kininogen.
Sakamoto W; Yoshikawa K; Uehara S; Nishikaze O; Handa H
J Biochem; 1984 Jul; 96(1):81-8. PubMed ID: 6238024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
